Multilocus sequence typing (MLST) is considered a reliable method for providing insight into the Streptococcus suis population structure, clonal relationships and the potential of particular clones to cause disease. Indeed, MLST has revealed the presence of several clonal complexes (CCs) within the Streptococcus suis population. However, the method is costly, time-consuming and difficult to use for screening large numbers of isolates. In this study, a multiplex PCR assay was developed to identify Streptococcus suis CCs that are relevant to human infections. The multiplex PCR assay was capable of simultaneously distinguishing CC1, CC25, CC28, CC104, CC221/234 and CC233/379, which are related to human infections in Thailand, in a single reaction. The multiplex PCR assay is useful for low-cost screening of large numbers of isolates with rapid analytical capacity and could be utilized in most laboratories.
INTRODUCTION
Streptococcus suis is a zoonotic pathogen that causes invasive infections in humans who have been in close contact with infected pigs or contaminated pork-derived products, or who have consumed raw pork products; thus, Streptococcus suis infections have attracted increasing attention worldwide (Goyette-Desjardins et al., 2014) . Multilocus sequence typing (MLST) can provide important insights into population structures. When applied to Streptococcus suis, this method revealed the presence of several clonal complexes (CCs) within the Streptococcus suis population (King et al., 2002) . Among the different CCs identified, CC1, CC20, CC25, CC28 (formerly referred to as CC27 with the less-stringent group definition), CC104 and CC221/234 are the most important causes of infections in humans and pigs (Goyette-Desjardins et al., 2014; Kerdsin et al., 2011a, b; King et al., 2002; Schultsz et al., 2012; Takamatsu et al., 2008a) .
Although highly informative, MLST is a high-cost and time-consuming method that is not ideal for screening large numbers of isolates. MLST is also unavailable in most laboratories, especially in developing countries. Therefore, a PCR-based method would be an attractive alternative for determining Streptococcus suis CCs, since it can be used to screen large numbers of isolates, has rapid analytical capacity, is low cost and can be applied in most laboratories. PCR assays have been successfully developed to identify CCs in Staphylococcus aureus and Acinetobacter baumannii (Feil et al., 2008; Turton et al., 2007) .
Here, we report on the development of a multiplex PCR assay capable of identifying Streptococcus suis CC104 and CC1, the major CCs responsible for human infections in Thailand and worldwide, respectively (Goyette-Desjardins et al. 
METHODS
Bacterial strains. A total of 647 Streptococcus suis strains with known serotypes, sequence types (STs) and clonal complexes isolated from humans were included in this study (Table 1) . Streptococcus suis serotype 2-ST104, strain DMST22713 isolated from a human with sepsis, and Streptococcus suis serotype 2-ST1, strain P1/7 isolated from pig meningitis, were used for a genomic subtraction experiment to identify the specific CC104 sequence.
Identification of specific sequence in Streptococcus suis CC104. Bacterial genome subtraction was performed using the PCRSelect Bacterial Genome Subtraction kit (Clontech Takara), according to the manufacturer's instructions. Genomic DNA from representative CC1 (Streptococcus suis serotype 2-ST1 strain P1/7) and CC104 (Streptococcus suis serotype 2-ST104 strain DMST22713) strains was extracted using the NucleoSpin Tissue kit (Macherey-Nagel), according to the manufacturer's instructions, and used as a driver and a tester, respectively. The PCR-amplification products of the tester-specific sequence (ST104) were then cloned into the StrataClone vector and transformed into Escherichia coli StrataClone SoloPack competent cells, according to the manufacturer's instructions (Stratagene). Recombinant clones were screened on LB agar plates supplemented with ampicillin, isopropyl b-D-1-thiogalactopyranoside and X-Gal. Confirmation of the inserted fragments was performed by PCR using M13 primers.
DNA sequencing of the positive clones was performed by First BASE, Malaysia. DNA sequence similarity analyses were completed using the National Center for Biotechnology Information BLAST network service. According to the BLAST search results, seven assembled sequences (derived from 62 clones) shared very low similarity with known Streptococcus suis sequences deposited in GenBank. These sequences were assigned accession numbers, as shown in Table 2 .
Distribution of CC104-specific sequences. Seven specific sequences were analysed by singleplex PCR for their distribution among different Streptococcus suis sequence types. The PCR primers used to amplify these seven sequences were designed using the Primer-BLAST program (accessed on 11 November 2014; http://www. ncbi.nlm.nih.gov/tools/primer-blast/) ( Table 2 ). The PCR mixtures contained 1| JumpStart REDTaq ReadyMix Reaction Mix (Sigma) and 0.5 mM of each primer pair ( Table 2 ). The following PCR thermocycling parameters were used: initial activation of DNA polymerase at 95 uC for 3 min; 30 cycles of denaturation at 95 uC for 20 s, primer annealing at 56 uC for 30 s, and extension at 72 uC for 2.5 min; with a final extension at 72 uC for 5 min.
The PCR products were resolved by gel electrophoresis for 30 min on 2 % agarose gels in 0.5| Tris/borate/EDTA (TBE) buffer. The gels were stained with ethidium bromide and visualized under UV light, using a GeneGenius Bioimaging System (SynGene). The sizes of the PCR products were determined by comparison with a molecular size standard (GeneRuler 100 bp Plus DNA ladder, Thermo Fisher Scientific).
Multiplex PCR detection of Streptococcus suis CCs. Multiplex PCR was performed using a final concentration of 1| JumpStart REDTaq ReadyMix Reaction Mix (Sigma) and 0.4 mM of each primer pair for the target genes hp1, col, mp, pep and srtBCD ( Table 2 ). The primer pair for srtBCD (Table 2) , described by Takamatsu et al. (2009) , was included in the multiplex PCR to detect CC1 strains. Thermocycling and the analysis of PCR products were performed as described above.
To evaluate the limit of detection of the multiplex PCR test, Streptococcus suis strains P1/7 and DMST22713 were diluted using 10-fold serial dilutions, starting from an original concentration of OD 600 50.6 (equivalent to 10 8 c.f.u. ml
21
). Genomic DNA was prepared from 1 ml of each dilution using the NucleoSpin Tissue kit (MachereyNagel). Each dilution was also plated onto sheep blood agar (0.5 % peptone, 0.3 % yeast extract, 0.5 % NaCl, 1.5 % agar, 5 % sheep blood, pH 7.4) for c.f.u. quantification to determine the minimum c.f.u. required for detection with the multiplex PCR.
RESULTS AND DISCUSSION
Identification of Streptococcus suis CC104-specific sequences Initially, we used bacterial genome subtraction to identify specific sequences using CC104 (representative strain, ST104) and CC1 (representative strain, ST1), as described in Methods. Using this approach, we identified 62 CC104-specific cloned fragments, the analysis of which revealed seven significant assembled sequences having low similarity with known Streptococcus suis sequences deposited in the GenBank database. These seven sequences encoded two hypothetical proteins (hp1 and hp2), one RNase G (ribG), one peptidase ( pep), one muramidaselike protein (mp), one zonula occludens toxin (zot) and one collagen adhesion (col), as shown in Table 2 .
As shown in Table 1 , hp1 and hp2 were highly specific to CC104 only, while pep, ribG, col and mp were also present in CC233/379. Analysis using eBURST (http://ssuis.mlst. net/eburst/) demonstrated that CC233/379 shared a double locus variant (gki and thrA) with CC104 (data not shown). Therefore, some specific sequences found in CC104 may also be present in CC233/379. However, most of the CC104-specific sequences were not found in CC1, except for ribG (10 %) and zot (44 % in ST1 and 40 % in ST105; Table 1 ). CC28 contained the pep and col genes (100 %), while CC25 was pep-positive (100 %) and only ST25 was zot-positive (100 %) ( Table 1 ). In addition, hp1 was present in CC221/234 as well as in CC104.
Multiplex PCR for Streptococcus suis CCs
To develop a multiplex PCR assay covering the major CCs of Streptococcus suis relevant to human infections, including CC1, CC25, CC28, CC104, CC221/234 and CC233/ 379 (Feil et al., 2008 , Kerdsin et al., 2011a ; http://ssuis. mlst.net/), we selected hp1, mp, pep and col of the CC104-specific sequences as targets for primer design, including the srtBCD primers described by Takamatsu et al. (2009) . This assay allows simultaneous differentiation of CC1, CC25, CC28, CC104, CC221/234 and CC233/379 in a single reaction. As shown in Fig. 1 , our multiplex PCR assay accurately differentiated Streptococcus suis strains of each CC, in agreement with previous MLST results. Multiplex reactions with CC104 strains generated four bands of 408, 901, 1420 and 1586 bp for the hp1, mp, pep and col genes, respectively, whereas reactions with CC233/379 strains resulted in three bands of 901 bp (mp), 1420 bp ( pep) and 1586 bp (col). Multiplex reactions with CC25 strains revealed only a single band (1420 bp) for pep, while CC28 strains showed two bands (1420 bp and 1586 bp), corresponding to pep and col, respectively. CC1 and CC221/234 strains showed only a single band: 2065 bp, which corresponded to srtBCD in CC1, and 408 bp for hp1 in CC221/234. These results demonstrated that multiplex PCR can be used to distinguish different CCs related to human infections. The limit of detection in the multiplex assay was 10 3 c.f.u. for both strains P1/7 and DMST22713, which are representative of CC1 and CC104, respectively (data not shown).
MLST is a powerful method for typing Streptococcus suis isolates, providing insight into population structures; however, development of other methods such as PCR to identify Streptococcus suis CCs would be useful for the rapid screening of numerous isolates at relatively low cost, and could be applied in most laboratories. To the best of our knowledge, only two reports have demonstrated the application of PCR in determining CCs in Streptococcus suis isolates. The first report revealed that a variant of serum opacity factor (ofs) can serve as a genetic marker to determine CCs of Streptococcus suis (Takamatsu et al., 2008b) . The report showed that type-1 ofs was strongly associated with CC1, while type-3 and type-4 ofs were associated with CC27. Importantly, CC25, CC28 and CC104 were included in CC27 with the lessstringent group definition used in that study (Takamatsu et al., 2008b) . However, type-3 ofs was present in both CC94 and CC27, making it difficult to distinguish one from another. Similarly, CC25 and CC104 could not be differentiated from CC27 (Takamatsu et al., 2008b) . ST393; 5, ST512; 6, ST513; 7, ST514; 8, ST233; 9, ST379; 10, ST28; 11, ST382; 12, ST25; 13, ST102; 14, ST103; 15, ST380; 16, ST381; 17, 395; 18, ST515; 19, ST516; 20, ST221; 21, ST234; 22, ST1; 23, ST126; 24, ST144; 25, ST298; 26, ST337; 27, ST394; 28, ST11;  29, ST105; 30, ST127; 31, ST237; 32, ST16; N, negative control; M, 100 bp DNA ladder.
A second study described a PCR assay to determine how pilus-associated gene profiles correlated with CCs of Streptococcus suis (Takamatsu et al., 2009 (Kerdsin et al., 2015) , our multiplex PCR assay could not be used to amplify this isolate (Table 1 , Fig. 1 ). Therefore, a whole-genome sequencing or allele-specific sequencing of this isolate is required to design specific primers for CC16 amplification, which is also important, although mainly for studying disease in pigs. Moreover, the multiplex PCR should be extended to validate the human CC strains isolated from different regions such as Europe and North America as well as the CC strains isolated from pigs. In conclusion, the assay developed in this study will be useful for screening or determining major CCs relevant to human isolates of Streptococcus suis. To investigate the STs in each CC, MLST should be performed.
